Beth McHugh makes a strong argument for doctors “not to explicitly discuss disease severity scale”.
But
(1) A valid informed consent would then become difficult
(2) Not discussing severity, is not a practical option for patients with certain illness.
Risk categorisation will continue to be the norm in future as genomic data leads to personalised medicine.
Dr S Sundar 